JP2010526859A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010526859A5 JP2010526859A5 JP2010507982A JP2010507982A JP2010526859A5 JP 2010526859 A5 JP2010526859 A5 JP 2010526859A5 JP 2010507982 A JP2010507982 A JP 2010507982A JP 2010507982 A JP2010507982 A JP 2010507982A JP 2010526859 A5 JP2010526859 A5 JP 2010526859A5
- Authority
- JP
- Japan
- Prior art keywords
- cmbp
- gly
- cys
- imaging agent
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0709441A GB0709441D0 (en) | 2007-05-16 | 2007-05-16 | Peptide imaging agents |
| GB0715682A GB0715682D0 (en) | 2007-08-13 | 2007-08-13 | Peptide imaging agents |
| PCT/GB2008/001696 WO2008139207A2 (en) | 2007-05-16 | 2008-05-16 | Labelled hgf binding peptides for imaging |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010526859A JP2010526859A (ja) | 2010-08-05 |
| JP2010526859A5 true JP2010526859A5 (enExample) | 2012-06-21 |
Family
ID=39743846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010507982A Pending JP2010526859A (ja) | 2007-05-16 | 2008-05-16 | ペプチドイメージング剤 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8529874B2 (enExample) |
| EP (1) | EP2146749B1 (enExample) |
| JP (1) | JP2010526859A (enExample) |
| KR (2) | KR20150017387A (enExample) |
| CN (1) | CN101848734B (enExample) |
| AT (1) | ATE551073T1 (enExample) |
| AU (1) | AU2008249821B2 (enExample) |
| BR (1) | BRPI0811210B1 (enExample) |
| CA (1) | CA2685553C (enExample) |
| ES (1) | ES2385066T3 (enExample) |
| IL (1) | IL201778A0 (enExample) |
| MX (1) | MX2009012386A (enExample) |
| NZ (1) | NZ581160A (enExample) |
| PL (1) | PL2146749T3 (enExample) |
| RU (2) | RU2473361C9 (enExample) |
| WO (1) | WO2008139207A2 (enExample) |
| ZA (1) | ZA200908016B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2148702A2 (en) * | 2007-05-16 | 2010-02-03 | GE Healthcare AS | Pentamethine cyanine dyes carrying at least three sulfonic acid groups |
| GB0718967D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Peptide imaging agents |
| GB0918321D0 (en) | 2009-10-20 | 2009-12-02 | Ge Healthcare As | Cyclic peptide synthesis |
| EP2588541A1 (en) * | 2010-06-29 | 2013-05-08 | GE Healthcare AS | Dye compositions and dye syntheses |
| GB201010878D0 (en) | 2010-06-29 | 2010-08-11 | Ge Healthcare As | Dye compositiion and dye syntheses |
| GB201013808D0 (en) | 2010-08-18 | 2010-09-29 | Ge Healthcare Ltd | Peptide radiotracer compositions |
| US20120088262A1 (en) * | 2010-10-06 | 2012-04-12 | Millipore Corporation | Cyanine compounds, conjugates and method of use |
| MX2013010012A (es) | 2011-03-01 | 2014-04-14 | Ge Healthcare Ltd | Analogos de octreotato radiomarcado como trazadores de tomografia por emision de positrones. |
| GB201103696D0 (en) | 2011-03-04 | 2011-04-20 | Ge Healthcare Ltd | Technetium labelled peptides |
| DE102011118029A1 (de) * | 2011-06-20 | 2012-12-20 | Universität Leipzig | Modifizierte antibiotische Peptide mit variabler systemischer Freisetzung |
| GB201116733D0 (en) | 2011-09-28 | 2011-11-09 | Ge Healthcare As | Peptide margin imaging agents |
| GB201116862D0 (en) | 2011-09-30 | 2011-11-09 | Ge Healthcare As | Infusion imaging method |
| GB201121914D0 (en) * | 2011-12-20 | 2012-02-01 | Ge Healthcare Ltd | Method for patient selection |
| US10046068B2 (en) * | 2013-03-15 | 2018-08-14 | Arizona Board Of Regents On Behalf Of Arizona State University | Saccharide conjugates |
| GB201314936D0 (en) | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
| GB201322456D0 (en) | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
| CN105111773B (zh) * | 2015-08-19 | 2017-06-27 | 大连理工大学 | 一类氨基菁类荧光染料及其制备方法和应用 |
| GB201804835D0 (en) * | 2018-03-26 | 2018-05-09 | Ge Healthcare As | Formulation and method of preparation |
| CN112129736B (zh) * | 2020-09-22 | 2022-08-02 | 四川大学华西医院 | 粘蛋白和循环肿瘤细胞的均相可视化/荧光poct检测方法 |
| WO2022258455A1 (en) * | 2021-06-07 | 2022-12-15 | Surgvision Gmbh | Stable liquid phantom for near-infrared fluorescence verification |
| TW202404643A (zh) | 2022-04-20 | 2024-02-01 | 大陸商同宜醫藥（蘇州）有限公司 | 化合物及用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7615646B2 (en) * | 2002-05-10 | 2009-11-10 | Carnegie Mellon University | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| GB0223249D0 (en) * | 2002-10-08 | 2002-11-13 | Amersham Plc | Improved imaging agents |
| US7510699B2 (en) * | 2003-02-19 | 2009-03-31 | Sicel Technologies, Inc. | In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
| ES2557286T3 (es) * | 2003-03-03 | 2016-01-25 | Dyax Corp. | Usos de péptidos que se unen específicamente al receptor del HGF (cMet) |
| NO20034350D0 (no) * | 2003-09-29 | 2003-09-29 | Amersham Health As | Optisk avbilding av kolorektal kreft |
| EP1678258B1 (en) * | 2003-10-31 | 2011-08-31 | GE Healthcare Limited | Cyanine dye labelling reagents |
| US7785566B2 (en) | 2003-11-06 | 2010-08-31 | Ge Healthcare, Inc. | Pharmaceutical compounds |
| NO20035682D0 (no) | 2003-12-18 | 2003-12-18 | Amersham Health As | Optisk avbildning av ösofagkreft og Barretts ösofag |
| US8236283B2 (en) * | 2005-01-06 | 2012-08-07 | Ge Healthcare As | Optical imaging |
| WO2006078914A1 (en) * | 2005-01-21 | 2006-07-27 | Washington University In St. Louis | Compounds having rd targeting motifs |
| GB0502277D0 (en) | 2005-02-04 | 2005-03-09 | Amersham Plc | Novel imaging agents |
| EP1877428B1 (en) * | 2005-04-22 | 2011-03-16 | University of Washington | Cyanine- chlorotoxin conjugate and method for intra-operative visualization of cancer |
| NO20053354D0 (no) | 2005-07-11 | 2005-07-11 | Amersham Health As | Optical imaging contrast agent. |
-
2008
- 2008-05-16 JP JP2010507982A patent/JP2010526859A/ja active Pending
- 2008-05-16 KR KR1020157002055A patent/KR20150017387A/ko not_active Ceased
- 2008-05-16 ES ES08750628T patent/ES2385066T3/es active Active
- 2008-05-16 EP EP08750628A patent/EP2146749B1/en active Active
- 2008-05-16 MX MX2009012386A patent/MX2009012386A/es active IP Right Grant
- 2008-05-16 PL PL08750628T patent/PL2146749T3/pl unknown
- 2008-05-16 CA CA2685553A patent/CA2685553C/en active Active
- 2008-05-16 WO PCT/GB2008/001696 patent/WO2008139207A2/en not_active Ceased
- 2008-05-16 AU AU2008249821A patent/AU2008249821B2/en not_active Expired - Fee Related
- 2008-05-16 RU RU2009140475/10A patent/RU2473361C9/ru active
- 2008-05-16 US US12/600,265 patent/US8529874B2/en not_active Expired - Fee Related
- 2008-05-16 CN CN2008800242291A patent/CN101848734B/zh not_active Expired - Fee Related
- 2008-05-16 RU RU2009140478/15A patent/RU2475266C2/ru not_active IP Right Cessation
- 2008-05-16 BR BRPI0811210-0A patent/BRPI0811210B1/pt not_active IP Right Cessation
- 2008-05-16 NZ NZ581160A patent/NZ581160A/en not_active IP Right Cessation
- 2008-05-16 AT AT08750628T patent/ATE551073T1/de active
- 2008-05-16 KR KR1020097023746A patent/KR101578225B1/ko not_active Expired - Fee Related
-
2009
- 2009-10-27 IL IL201778A patent/IL201778A0/en unknown
- 2009-11-13 ZA ZA2009/08016A patent/ZA200908016B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7664158B2 (ja) | トランスフェリン受容体標的ペプチド | |
| AU2022202280B2 (en) | Controlled-release CNP agonists with low initial NPR-B activity | |
| JP7748358B2 (ja) | リラキシン類似体およびその使用方法 | |
| AU2022221482B2 (en) | Controlled-release CNP agonists with low NPR-C binding | |
| US8431111B2 (en) | Peptide imaging agents | |
| EP2146749B1 (en) | Labelled hgf binding peptides for imaging | |
| AU2017205273C1 (en) | Controlled-release CNP agonists with reduced side-effects | |
| AU2019246196B2 (en) | Formulation and method of preparation | |
| JP2023506952A (ja) | インクレチン類似体およびその使用 | |
| IL259659B (en) | Controlled-release cnp agonists with increased nep stability | |
| JP2026071260A (ja) | Ｃｒｆ２受容体アゴニスト及び治療におけるその使用 | |
| TWI820657B (zh) | 針對vegf之d-肽化合物 | |
| JP5604305B2 (ja) | 線維症の非侵襲性の特異的イメージングのための、ポリペプチド、環状ポリペプチドおよびそれを含む医薬 | |
| HK40111230A (en) | Cleavable radioligands for targeting cell surface receptors and uses thereof | |
| AU2013211503A1 (en) | FGF21 mutants and uses thereof | |
| HK40047564A (en) | Formulation and method of preparation | |
| HK40047564B (en) | Formulation and method of preparation | |
| HK1148476A (en) | Labelled hgf binding peptides for imaging |